6h
The Manila Times on MSNPH targets larger share of health care info marketTHE country wants to further expand its share of North America's health care outsourcing market, confident of its strengths ...
Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...
Shares of Hims & Hers Health (NYSE: HIMS) sank 10.5% this week, according to data from S&P Global Market Intelligence. The ...
Hims & Hers Health stock drops over 20% after the FDA removes semaglutide from the shortage list. Novo Nordisk launches a ...
Andrew Dudum is making it abundantly clear Hims is a healthcare company, not a cosmetic wellness brand. Ms. Manuel is a foreign policy expert and former U.S. government official who specializes in ...
Hims & Hers Health shares jumped some 20% to a record high on Wednesday following the announcement that it acquired lab testing facility Trybe Labs.
Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in Novo Nordisk’s Wegovy and Ozempic has been resolved.
Many treatments are available, and with the popularity of online and mail-order services in recent years, two leaders are BlueChew and Hims. Both companies offer different ED treatments and a ...
We recently published an article titled Jim Cramer Discusses These 12 Stocks & Says Late Selloffs Are Deliberate. In this ...
RKLX, the Defiance Daily Target 2X Long RKLB ETF, seeks daily investment results that correspond to twice (200%) the daily percentage change of Rocket Lab, a company at the forefront of satellite ...
Although Hims & Hers is saying it will still make its own compounded GLP-1 drugs in 2025, it is up in the air whether the U.S. government or court systems will allow the company to sell these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results